US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Monkeypox Concept

2,071.10

+27.581.35%

Number of Gainers:5

Number of Losers:5

Number of Flat:1

PE:- -

High:2,094.79

Open:2,056.63

Low:2,050.42

Close:2,043.52

Volume:19.59M

Turnover:1.09B

Market Cap:228.21B

Float Cap:227.51B

Loading ...

SoftOx Names Dr. Bruce Montgomery to Chair Clinical Advisory Board

Xilio Therapeutics Names Yariv Houvras Chief Medical Officer

Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared to Competitors

Quest Diagnostics Inc. Stock Outperforms Competitors on Strong Trading Day

Health Rounds: Genetic Discovery Yields Clues Toward Reversal of Alzheimer's Brain Damage

Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors

DaVita Inc. Stock Falls 4.6%, Underperforms Peers

Analysts Offer Insights on Healthcare Companies: Aethlon Medical (AEMD) and Kyverna Therapeutics, Inc. (KYTX)

Inovio Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared to Competitors

Viatris Facing Multiple Paths to Earnings Growth, Oppenheimer Says

MT Newswires Live

Viatris Price Target Announced at $25.00/Share by Oppenheimer

Oppenheimer Initiates Viatris at Outperform With $25 Price Target

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), AnaptysBio (ANAB) and Vertex Pharmaceuticals (VRTX)

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Quest Diagnostics to Report Q3 Results, Host Conference Call Before Market Open

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/BK4583/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4583\",,,,,undefined,":{"symbol":"BK4583","market":"US","secType":"PLATE","nameCN":"Monkeypox Concept","latestPrice":2071.0994,"timestamp":1791403199999,"preClose":2043.5231,"halted":0,"volume":19586308,"delay":0,"changeRate":0.013494,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":27.576294,"latestTime":"10-07 16:00:00 EDT","open":2056.6323,"high":2094.7913,"low":2050.421,"amount":1093360359.14185,"amplitude":0.021713,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791417600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":6.581376,"peRate":-74.672799,"turnoverRate":0.007248,"increases":5,"decrements":5,"flats":0,"marketCap":228209658208.125,"floatMarketCap":227505089516.375},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4583\",,,,,undefined,":{"symbol":"BK4583","high":2094.7913,"amplitude":0.021713,"preClose":2043.5231,"low":2050.421,"pbRate":"6.581376","latestPrice":2071.0994,"volume":19586308,"delay":0,"open":2056.6323,"prevYearClose":1682.3505,"prevWeekClose":2054.7417,"prevMonthClose":2104.65,"prevQuarterClose":2104.65,"fiveDayClose":2104.65,"twentyDayClose":2046.7563,"sixtyDayClose":1841.0508,"secType":"PLATE","market":"US","turnoverRate":0.007248,"peRate":-74.672799,"marketCap":228209658208.125,"floatMarketCap":227505089516.375,"timestamp":1791403199999,"nameCN":"Monkeypox Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4583\",,,,undefined,":{"bkCode":"BK4583","up":5,"down":5,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4583\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671329926","title":"SoftOx Names Dr. Bruce Montgomery to Chair Clinical Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2671329926","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671329926?lang=en_us&edition=fundamental","pubTime":"2026-09-29 15:23","pubTimestamp":1790666588,"startTime":"0","endTime":"0","summary":"SoftOx names Dr. Bruce Montgomery to chair Clinical Advisory BoardSoftOx appointed Dr. A. Bruce Montgomery to establish and chair its Clinical Advisory Board ahead of a planned Phase 2b SIS study.Boar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDLbDg5Mx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU0234570918.USD","LU1778281490.HKD","BK4568","LU1057294990.SGD","LU1839511570.USD","LU1934455277.USD","BMED","LU0965509010.AUD","LU1571399168.USD","LU0965509283.SGD","BK4583","LU1674673428.USD","LU0058720904.USD","LU2089984988.USD","TMED","LU1066053197.SGD","LU1066051498.USD","IE00BSNM7G36.USD","BK4139","BK4588","BBH","SG9999015986.USD","IBB","BIB","LU2112291526.USD","IE0002270589.USD","IBBQ","LU0289739699.SGD","IE00BZ1G4Q59.USD","IE00B7SZLL34.SGD","LU1934455863.HKD","LU0823416689.USD","TBXU","LU0882574055.USD","LU1934455194.USD","MEDI","BK4585","LU2357627491.SGD","LU0859254822.USD","LU0965509101.SGD","BK4578","SG9999015978.USD","IE00B3T34201.USD","BK4550","GILD","LU1061106388.HKD","BK4566","IE00B19Z3B42.SGD","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670019231","title":"Xilio Therapeutics Names Yariv Houvras Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2670019231","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670019231?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:30","pubTimestamp":1790595055,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics names Yariv Houvras chief medical officerXilio Therapeutics named Yariv J. Houvras chief medical officer on Sept. 28, 2026.He previously led clinical and translational development a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL8GCH5H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","LU0861579265.USD","LU1934455863.HKD","LU2112291526.USD","IE00B19Z3581.USD","IE00BQXX3C00.GBP","BCDF","LU0965509283.SGD","LU1934455277.USD","LU1839511570.USD","BIB","LU0823416689.USD","SG9999015952.SGD","LU1061106388.HKD","LU2210149790.SGD","SG9999014021.USD","LU2089984988.USD","TBXU","IE00BKPKM429.USD","BK4566","LU1430594728.SGD","BK4568","BK4583","LU1571399168.USD","IE00B19Z3B42.SGD","TMED","LU1066051498.USD","IBB","LU1037948897.HKD","LU2468319806.SGD","IE00B3QW5Z07.USD","BBH","MEDI","IE00BN0W2W23.USD","LU2087621335.USD","NDAQ","IE00BN0W2V16.EUR","IE00BKVL7J92.USD","GILD","LU0859254822.USD","LU2210150020.SGD","LU1066053197.SGD","SG9999014013.SGD","IE00B3T34201.USD","LU0965509101.SGD","XLO","BK4532","IBBQ","SG9999015978.USD","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670137914","title":"Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2670137914","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670137914?lang=en_us&edition=fundamental","pubTime":"2026-09-25 05:25","pubTimestamp":1790285100,"startTime":"0","endTime":"0","summary":"DJ Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Inovio Pharmaceuticals Inc.  slipped 3.20% to $1.21 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.01% to 26,939.37 and the Dow Jones Industrial Average  falling 0.31% to 51,349.98.This was the stock's second consecutive day of losses.Inovio Pharmaceuticals Inc. closed 55.51% below its 52-week high of $2.72, which the company reached on December 17th.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  rose 0.56% to $270.68, Statera Biopharma Inc.  remained unchanged, and Pfizer Inc.  rose 0.82% to $28.41.Trading volume  remained 1.4 million below its 50-day average volume of 4.3 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 24, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","INO","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670413634","title":"Quest Diagnostics Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2670413634","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670413634?lang=en_us&edition=fundamental","pubTime":"2026-09-25 05:01","pubTimestamp":1790283660,"startTime":"0","endTime":"0","summary":"DJ Quest Diagnostics Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Quest Diagnostics Inc.  rallied 1.54% to $236.59 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.02% to 7,704.13 and Dow Jones Industrial Average  falling 0.31% to 51,349.98.The stock's rise snapped a four-day losing streak.Quest Diagnostics Inc. closed 4.92% short of its 52-week high of $248.84, which the company achieved on September 21st.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as UnitedHealth Group Inc.  rose 1.00% to $375.01, IQVIA Holdings Inc.  rose 2.67% to $275.02, and Centene Corp.  fell 0.26% to $61.92.Trading volume  remained 129,158 below its 50-day average volume of 1.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 24, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4567","BK4585","LU2506951875.HKD","LU1854103824.USD","BK4588","DGX","LU2506951958.HKD","LU1854104046.USD","LU2506952097.USD","LU2506952170.USD","LU0950375773.USD","BK4196","BK4583","LU0823417737.USD","LU0823417653.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670413895","title":"Health Rounds: Genetic Discovery Yields Clues Toward Reversal of Alzheimer's Brain Damage","url":"https://stock-news.laohu8.com/highlight/detail?id=2670413895","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670413895?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:50","pubTimestamp":1790283042,"startTime":"0","endTime":"0","summary":"Health Rounds: Genetic discovery yields clues toward reversal of Alzheimer's brain damageSept 24 -Hello Health Rounds readers!","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL1N45G0ZF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMED","SG9999015945.SGD","BK4588","LU0965509101.SGD","BIB","IE00B7SZLL34.SGD","LU0823416689.USD","BK4550","LU0882574055.USD","LU1934455194.USD","LU0114720955.EUR","LU0122379950.USD","LU0861579265.USD","TBXU","LU0320765992.SGD","LU0234570918.USD","LU2089984988.USD","BK4139","LU0058720904.USD","BK4585","BK4532","LU1585245621.USD","BBH","BK4578","LU1061106388.HKD","LU2324357040.USD","IBBQ","LU1674673428.USD","LU0965509010.AUD","BK4568","LU2087621335.USD","SG9999015978.USD","IE0002270589.USD","LU1037948897.HKD","MEDI","IE00B19Z3581.USD","IE00BKVL7J92.USD","LU2357627491.SGD","IBB","LU0289739699.SGD","LU1037948541.HKD","LU1934455277.USD","IE00B19Z3B42.SGD","LU1023059063.AUD","GILD","SG9999015952.SGD","BK4583","LU1934455863.HKD","IE00BSNM7G36.USD","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670180864","title":"Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2670180864","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670180864?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:35","pubTimestamp":1790282100,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slipped 1.11% to $149.69 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.02% to 7,704.13 and Dow Jones Industrial Average  falling 0.31% to 51,349.98.This was the stock's second consecutive day of losses.Gilead Sciences Inc. closed 4.83% below its 52-week high of $157.29, which the company achieved on February 11th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson  rose 0.56% to $270.68, Pfizer Inc.  rose 0.82% to $28.41, and Abbott Laboratories  fell 2.34% to $101.07.Data source: Dow Jones Market Data, FactSet. Data compiled September 24, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","IE00B19Z3B42.SGD","BBH","IBBQ","LU0122379950.USD","LU1934455194.USD","BK4139","LU2087621335.USD","LU1674673691.USD","IE00B19Z3581.USD","LU2112291526.USD","TMED","IBB","LU0861579265.USD","BK4588","LU0965509101.SGD","IE00BKVL7J92.USD","LU1061106388.HKD","SG9999015986.USD","TBXU","SG9999015978.USD","LU0965508806.USD","IE0002270589.USD","LU0320765992.SGD","LU0859254822.USD","BK4585","IE00B7SZLL34.SGD","LU0114720955.EUR","LU0889565916.HKD","LU0058720904.USD","LU1037948897.HKD","MEDI","LU1934455277.USD","IE00BSNM7G36.USD","LU0882574055.USD","BIB","LU1571399168.USD","BMED","LU1585245621.USD","LU0823416689.USD","IE00B3T34201.USD","IE00BZ1G4Q59.USD","LU0234570918.USD","LU1674673428.USD","BK4583","LU1023059063.AUD","LU2089984988.USD","BK4550","LU0289739699.SGD","LU1430594728.SGD","LU2357627491.SGD","SG9999015952.SGD","LU1066053197.SGD","LU1057294990.SGD","LU2468319806.SGD","LU1839511570.USD","BK4566","BK4568","LU1037948541.HKD","SG9999015945.SGD","LU0965509010.AUD","BK4532","LU2324357040.USD","LU1066051498.USD","LU1934455863.HKD","LU0965509283.SGD","BK4578","LU1778281490.HKD","GILD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670242418","title":"DaVita Inc. Stock Falls 4.6%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2670242418","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670242418?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:34","pubTimestamp":1790282040,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of DaVita Inc. shed 4.6% to $174.67 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index remaining mostly unchanged at 7,704.13 and the Dow Jones Industrial Average falling 0.3% to 51,349.98.This was the stock's second consecutive day of losses.DaVita Inc. closed 29.4% below its 52-week high of $247.49, which the company reached on August 3rd.The stock underperformed when compared to some of its peers, as UnitedHealth Group Inc. rose 1.0% to $375.01, Icon PLC rose 6.1% to $173.90, and Quest Diagnostics Inc. rose 1.54% to $236.59.Trading volume totaled 779,277, compared to the 50-day average of 816,176.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362541513.USD","LU0994945656.USD","LU1854103824.USD","LU0289739343.SGD","LU2244417387.USD","DGX","LU0976567544.SGD","LU1854104046.USD","BK4585","LU0211326839.USD","LU0426417589.USD","LU0069063385.USD","BK4196","LU0472753341.HKD","LU0057025933.USD","ICLR","BAIV","LU0496365809.HKD","LU1267930813.SGD","LU0823417737.USD","LU1791710582.SGD","BK4583","LU0175139822.USD","LU0511384066.AUD","LU1043141123.HKD","LU1267930227.SGD","LU0882574055.USD","LU0128525689.USD","LU1804176565.USD","LU0289960550.SGD","LU2506951875.HKD","LU0128525929.USD","LU0052756011.USD","LU2506952097.USD","BK4588","BK4559","LU2362541273.HKD","DVA","LU0029864427.USD","BK4121","LU0289961442.SGD","LU1043141396.HKD","LU0728928796.USD","LU0528227936.USD","LU0792757196.USD","LU1691799644.USD","BK4567","LU0708994859.HKD","LU0889566641.SGD","LU0950375773.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669049359","title":"Analysts Offer Insights on Healthcare Companies: Aethlon Medical (AEMD) and Kyverna Therapeutics, Inc. (KYTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669049359","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669049359?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:50","pubTimestamp":1790254216,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Aethlon Medical (AEMD) and Kyverna Therapeutics, I...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-aethlon-medical-aemd-and-kyverna-therapeutics-inc-kytx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-aethlon-medical-aemd-and-kyverna-therapeutics-inc-kytx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BK4588","BK4139","KYTX","AEMD","XLV","LU0029874061.USD","BK4585","HCSG","XBI","BK4583","BK4137","LABU","BK4581","BK4568","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669439260","title":"Inovio Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2669439260","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669439260?lang=en_us&edition=fundamental","pubTime":"2026-09-24 05:24","pubTimestamp":1790198640,"startTime":"0","endTime":"0","summary":"DJ Inovio Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Inovio Pharmaceuticals Inc.  slid 3.10% to $1.25 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index  falling 1.13% to 26,936.04 and Dow Jones Industrial Average  falling 0.68% to 51,511.59.Inovio Pharmaceuticals Inc. closed 54.04% below its 52-week high of $2.72, which the company reached on December 17th.The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson  fell 0.01% to $269.17, Statera Biopharma Inc.  remained unchanged, and Pfizer Inc.  rose 0.90% to $28.18.Trading volume  remained 1.2 million below its 50-day average volume of 4.3 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 23, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INO","BK4583","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669487784","title":"Viatris Facing Multiple Paths to Earnings Growth, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2669487784","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669487784?lang=en_us&edition=fundamental","pubTime":"2026-09-24 00:01","pubTimestamp":1790179296,"startTime":"0","endTime":"0","summary":"Viatris (VTRS) is facing multiple paths to earnings growth with an improving base business and a late-stage pipeline that includes two potential blockbuster assets, Oppenheimer said in a Wednesday not","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4583","LU2087621335.USD","BK4007","BK4585","VTRS","LU1839511570.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669858274","title":"Viatris Price Target Announced at $25.00/Share by Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2669858274","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669858274?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:15","pubTimestamp":1790165700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VTRS/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1839511570.USD","BK4588","LU2087621335.USD","BK4583","VTRS","BK4007","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669107789","title":"Oppenheimer Initiates Viatris at Outperform With $25 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2669107789","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669107789?lang=en_us&edition=fundamental","pubTime":"2026-09-23 18:39","pubTimestamp":1790159993,"startTime":"0","endTime":"0","summary":"Viatris (VTRS) has an average rating of overweight and mean price target of $19.67, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4583","LU2087621335.USD","VTRS","BK4588","LU1839511570.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669711101","title":"Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), AnaptysBio (ANAB) and Vertex Pharmaceuticals (VRTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669711101","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669711101?lang=en_us&edition=fundamental","pubTime":"2026-09-23 17:10","pubTimestamp":1790154626,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Quest Diagnostics (DGX), AnaptysBio (ANAB) and Verte...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-quest-diagnostics-dgx-anaptysbio-anab-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-quest-diagnostics-dgx-anaptysbio-anab-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNMX","BIB","FFTY","LABU","LU1815336091.USD","LU0757428866.USD","LU0823417737.USD","VERX","LU2506951875.HKD","LU0823416689.USD","VRTX","TBXU","XBI","LU0234570918.USD","LU2506952170.USD","LU2089984988.USD","XLV","DGX","LU0823417653.USD","BK4139","SGXZ57979304.SGD","BK4567","LU2456880835.USD","LU1585245621.USD","BBH","LU0079474960.USD","IBBQ","IE00BJT1NW94.SGD","SG9999001176.USD","LU0417517546.SGD","LU1854103824.USD","HCSG","IE0002270589.USD","IE00BJJMRZ35.SGD","LU0109394709.USD","LU2462157665.USD","PBE","LU2506952097.USD","IE00B2B36J28.USD","IBB","LU0289739699.SGD","IE00B19Z3B42.SGD","LU1093756325.SGD","ANAB","IE00BZ9MQY76.HKD","BK4583","SG9999001176.SGD","LU1035775433.USD","IE0009355771.USD","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669171122","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2669171122","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669171122?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:34","pubTimestamp":1790109240,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rallied 1.40% to $152.67 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index  remaining mostly unchanged at 7,764.64 and the Dow Jones Industrial Average  falling 0.36% to 51,863.69.This was the stock's second consecutive day of gains.Gilead Sciences Inc. closed 2.94% below its 52-week high of $157.29, which the company achieved on February 11th.The stock outperformed some of its competitors Tuesday, as Johnson & Johnson  fell 0.10% to $269.19, Pfizer Inc.  rose 0.68% to $27.93, and Abbott Laboratories  rose 0.69% to $103.69.Trading volume  remained 1.3 million below its 50-day average volume of 6.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 22, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU1934455277.USD","BK4578","LU1061106388.HKD","LU0122379950.USD","LU0114720955.EUR","LU1674673691.USD","BIB","SG9999015952.SGD","LU0320765992.SGD","LU0859254822.USD","TMED","BK4583","LU0965509010.AUD","BK4568","LU2468319806.SGD","LU1023059063.AUD","IE00B19Z3581.USD","IE00B7SZLL34.SGD","LU0965508806.USD","BBH","LU0109394709.USD","LU1585245621.USD","LU2089984988.USD","LU0289739699.SGD","LU1057294990.SGD","BK4566","LU1571399168.USD","MEDI","LU0823416689.USD","LU2324357040.USD","LU1430594728.SGD","LU0965509101.SGD","IE00B19Z3B42.SGD","IE00B3T34201.USD","LU0882574055.USD","LU1934455863.HKD","LU2357627491.SGD","LU0861579265.USD","IE00BZ1G4Q59.USD","SG9999015986.USD","LU1839511570.USD","GILD","IE00BKVL7J92.USD","LU1066053197.SGD","BK4585","SG9999015978.USD","LU0234570918.USD","LU1066051498.USD","IBB","BMED","LU2087621335.USD","LU1037948541.HKD","IE00BSNM7G36.USD","SG9999015945.SGD","BK4139","LU0889565916.HKD","TBXU","LU2112291526.USD","LU0965509283.SGD","BK4550","BK4588","LU0058720904.USD","LU1778281490.HKD","LU1934455194.USD","IBBQ","LU1037948897.HKD","IE0002270589.USD","LU1674673428.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669122915","title":"Quest Diagnostics to Report Q3 Results, Host Conference Call Before Market Open","url":"https://stock-news.laohu8.com/highlight/detail?id=2669122915","media":"Reuters","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669122915?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:29","pubTimestamp":1790108940,"startTime":"0","endTime":"0","summary":"Quest Diagnostics to report Q3 results, host conference call before market openQuest Diagnostics will report third-quarter 2026 financial results on Oct. 22, 2026, before the market opens.Quarterly re","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL6TMcXn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2506952097.USD","BK4567","LU2506951875.HKD","BK4585","BK4583","LU2506951958.HKD","LU1854103824.USD","BK4588","LU0823417653.USD","LU1854104046.USD","DGX","BK4196","LU0823417737.USD","LU2506952170.USD","LU0950375773.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":55,"code":"91000000","status":"200"}]}}